Aptus Pharma Limited (BOM:544529)
India flag India · Delayed Price · Currency is INR
492.50
-4.50 (-0.91%)
At close: Nov 16, 2026

Aptus Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
8,4462,395----
Market Cap Growth
710.03%-----
Enterprise Value
8,5492,334----
Last Close Price
492.50139.66----

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
105.6051.85----
PS Ratio
10.415.14----
PB Ratio
29.7210.26----
P/TBV Ratio
29.7710.29----

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
10.545.01----
EV/EBITDA Ratio
69.0031.31----
EV/EBIT Ratio
72.4733.12----

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
0.430.311.492.722.021.48
Debt / EBITDA Ratio
0.980.962.143.333.374.49
Net Debt / Equity Ratio
0.360.260.742.251.531.17
Net Debt / EBITDA Ratio
0.830.831.062.762.553.56
Net Debt / FCF Ratio
-0.73-0.79-2.09-1.75-3.14-
Asset Turnover
1.721.421.542.202.723.18
Inventory Turnover
3.292.081.732.382.583.52
Quick Ratio
1.631.020.901.040.941.01
Current Ratio
2.671.831.632.031.821.74
Return on Equity (ROE)
31.72%30.48%69.49%56.41%24.95%18.71%
Return on Assets (ROA)
15.67%13.46%17.95%10.62%5.83%4.49%
Return on Invested Capital (ROIC)
22.32%24.55%36.70%22.33%15.03%9.82%
Return on Capital Employed (ROCE)
32.90%29.10%46.60%23.30%15.40%12.40%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
0.95%1.93%----
FCF Yield
-1.67%-3.25%----
Buyback Yield / Dilution
2.95%-22.08%-224.21%-105.42%0.02%-16.87%